# Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy

> **NCT02133222** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 22 (actual)

## Conditions studied

- Metastatic (Stage IV) Melanoma

## Interventions

- **PROCEDURE:** blood sample

## Key facts

- **NCT ID:** NCT02133222
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-07
- **Final completion:** 2016-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02133222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02133222, "Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02133222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*